Colgate-Palmolive’s (NYSE: CL) stock faced a downturn as the company’s future guidance failed to align with investor expectations, despite a strong fourth-quarter earnings beat. The personal care ...

Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company ...

This story incorporates reporting from AOL, MarketWatch on MSN.com and Seeking Alpha on MSN.com.Colgate-Palmolive’s stock ...

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

President Brian Casey, Bret Stephens, and Goldie Blumenstyk ’79 kick off Colgate’s spring 2025 Presidential Speaker Series, “The University and the Public Good: The Role of the American College in Our ...

Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected ...

Goldman Sachs analyst Bonnie Herzog maintains a Buy rating on Colgate-Palmolive, with a price target of $106. Despite Q4 EPS of $0.91 exceeding expectations, organic sales growth of 4.3% fell short.

Colgate-Palmolive shares dropped Friday after the household products company missed revenue forecasts and gave weak guidance as it was hurt by foreign exchange rates.

Buying Colgate-Palmolive Company shares after their 20% drop may not be a good idea for dividend or total return investors.

Vice President for Equity and Inclusion Renee Madison and Title IX Coordinator Amy Gordon announced Jan. 21 via email to the ...

Colgate-Palmolive Co. shares are down 3.8% in premarket trades despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue ...

"Our (sales) guidance includes the impact of the planned exit from private label pet nutrition over the course of 2025," said ...